Double-blind, randomized comparison of itraconazole capsules and placebo in onychomycosis of toenail.
Jones
H E
HE
Department of Dermatology, University of Southern Alabama School of Medicine, Mobile, USA.
Zaias
N
N
D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D000368:Aged; D000935:Antifungal Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D002214:Capsules; D003967:Diarrhea / Q000139:chemically induced; D004311:Double-Blind Method; D005260:Female; D005500:Follow-Up Studies; D005533:Foot Dermatoses / Q000188:drug therapy*; D006261:Headache / Q000139:chemically induced; D006801:Humans; D017964:Itraconazole / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D014009:Onychomycosis / Q000188:drug therapy*; D010919:Placebos; D012074:Remission Induction; D012220:Rhinitis / Q000139:chemically induced; D012852:Sinusitis / Q000139:chemically induced; D014249:Trichophyton / Q000302:isolation & purification
D000935:Antifungal Agents; D002214:Capsules; D010919:Placebos; D017964:Itraconazole